awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42037461-D4EC3A40-EE8C-4259-8074-C9772C8B9E24
Q42037461-D4EC3A40-EE8C-4259-8074-C9772C8B9E24
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42037461-D4EC3A40-EE8C-4259-8074-C9772C8B9E24
Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2
P2860
Q42037461-D4EC3A40-EE8C-4259-8074-C9772C8B9E24
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42037461-D4EC3A40-EE8C-4259-8074-C9772C8B9E24
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
db4ac972e1491aaf39e5e1016625c8d3cf411281
P2860
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer